SCHEMBL4886683

SCHEMBL4886683

O=C(O)c1cnc(-c2ncc(C(=O)O)cn2)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
HSD17B10 Q99714 2/20 0.58
KDM4E B2RXH2 1/20 0.58
ALOX15 P16050 1/20 0.58
HCAR2 Q8TDS4 4/20 0.57
P4HA1 P13674 3/20 0.56
P4HTM Q9NXG6 2/20 0.56
MIF P14174 1/20 0.54
NAPRT Q6XQN6 3/20 0.52
GABRP O00591 1/20 0.52
GABRD O14764 1/20 0.52
GABRA1 P14867 1/20 0.52
GABRB1 P18505 1/20 0.52
GABRG2 P18507 1/20 0.52
GABRB3 P28472 1/20 0.52
GABRA5 P31644 1/20 0.52
GABRA3 P34903 1/20 0.52
GABRA2 P47869 1/20 0.52
GABRB2 P47870 1/20 0.52
GABRA4 P48169 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16749632 0.92 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL3219936 0.89 ALDH1A1 (0.50) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL29049636 0.84 XDH (0.56) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL185448 0.82 ALDH1A1 (0.54) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL3705899 0.82 ALDH1A1 (0.54) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL186175 0.80 GABRP (0.58) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL29345465 0.80 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL5660197 0.80 P4HA1 (0.56) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL4600260 0.80 ALDH1A1 (0.52) ALDH1A1HSD17B10KDM4EALOX15HCAR2
SCHEMBL63857 0.80 NAPRT (0.58) ALDH1A1HSD17B10KDM4EALOX15HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306315-A1 Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation UNIVERSITETET I OSLO (NO) 2008-12-11 US disclosed
EP-1909958-A2 METAL-ORGANIC FRAMEWORK CATALYSTS AND THEIR USE IN HYDROCARBON TRANSFORMATION Universitetet I Oslo (NO) 2008-04-16 EP disclosed
WO-2007007113-A2 METAL-ORGANIC FRAMEWORK CATALYSTS AND THEIR USE IN HYDROCARBON TRANSFORMATION UNIVERSITETET I OSLO (NO) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306315-A1 Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation POF1B, PMS2, IDH1 ALDH1A1 1365/4885HSD17B10 1649/4885KDM4E 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.